Table 3.
30 minutes | 1 hour | 2 hours | |
---|---|---|---|
Pain relief for the first 2 migraines in each treatment period, percentage of subjects who treated ≥2 attacks in both periods | |||
AVP-825 (n = 165) | 37.6 | 52.1 | 64.2 |
Oral sumatriptan (n = 165) | 18.8 | 45.5 | 62.4 |
P value | <.001 | .20 | .80 |
Pain relief for ≥2 of the first 3 migraines in each treatment period, percentage of subjects who treated ≥3 attacks in both periods | |||
AVP-825 (n = 140) | 51.4 | 71.4 | 83.6 |
Oral sumatriptan (n = 140) | 33.6 | 64.3 | 81.4 |
P value | <.001 | .17 | .68 |
Pain relief for 3 of the first 3 migraines in each treatment period, percentage of subjects who treated ≥3 attacks in both periods | |||
AVP-825 (n = 140) | 27.1 | 41.4 | 57.9 |
Oral sumatriptan (n = 140) | 12.1 | 40.7 | 57.1 |
P value | <.001 | 1.0 | 1.0 |
Pain relief is defined as reduction of Headache Severity score from moderate or severe to none or mild.
P values are based on McNemar’s test.